OpenVSafe by OpenVAERS
Search V-safe

3T2-24671-56882

5 vaccinations 8 coded responses 57 check-ins 8 free-text entries 3 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
190 / PA
Registered
2021-02-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-16
    Registered in v-safe
  2. 2021-02-16
    Dose 1 — Moderna
  3. 2021-02-16
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  4. 2021-02-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-02-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea, Abdominal pain
    Adult check-in
  9. 2021-02-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-23
    Survey response — day 7, dose 1
    MedDRA: Lymph node pain, Rhinorrhoea — Feeling: Fair · Fatigue or tiredness
    Free text: Runny nose; tender lymph nodes in neck on left side
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-09
    Survey response — day 21, dose 1
    MedDRA: Fatigue, Lymph node pain — Feeling: Good
    Free text: Tender neck lymph nodes again (first experienced last Tuesday) and fatigue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-16
    Dose 2 — Moderna
  14. 2021-03-16
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-03-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Impaired driving ability — Feeling: Good · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Briefly light-headed in a.m. so did not drive today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-03-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  19. 2021-03-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-23
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-03-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-06
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-27
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-06-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-09-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-10-26
    Dose 3 — Moderna
  30. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Joint pains, Fatigue or tiredness
    Adult check-in
  31. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  32. 2021-10-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  33. 2021-10-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Itching · None
    Adult check-in
  34. 2021-11-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-11-02
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-11-09
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-16
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-23
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-30
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-07
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-01-25
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-03-30
    Dose 4 — Moderna
  43. 2022-04-18
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  44. 2022-04-20
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-04-27
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-05-04
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  47. 2022-05-11
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-06-29
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  49. 2022-09-26
    Dose 5 — Moderna
  50. 2022-09-27
    Survey response — days 1–6 daily, dose 5
    MedDRA: Dizziness, Hyperhidrosis, Tinnitus — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sweating and feeling of faintness this morning, and tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-09-28
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain · None
    Adult check-in
  52. 2022-09-29
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  53. 2022-09-30
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  54. 2022-10-01
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  55. 2022-10-02
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  56. 2022-10-03
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  57. 2022-10-10
    Survey response — day 14, dose 5
    MedDRA: Pre-existing disease, Rosacea — Feeling: Good
    Free text: Worsening of rosacea, for which I am applying my existing prescription for metronidazole cream
    MedDRA releases: 2024-11 · check-in free text available
  58. 2022-10-17
    Survey response — day 21, dose 5
    MedDRA: Contact lens intolerance, Corrective lens user, Dry eye, Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Skin rash and dry eye, which started a few days after vaccination, has not significantly improved. I am following ophthalmologist advice for home care and have a follow up appointment on Friday. I have been unable to wear contact lenses. · Healthcare visit (other): Visit to doctor office
    MedDRA releases: 2024-11 · check-in free text available
  59. 2022-10-17
    Report sent to call center — day 21, dose 5
    Get care from a doctor or other healthcare professional
    1 call case(s)
  60. 2022-10-18
  61. 2022-10-18
    Call successful
    Participant prefers to complete VAERS report online
  62. 2022-10-24
    Survey response — day 28, dose 5
    MedDRA: Dry eye, Office visit, Pre-existing disease, Rosacea — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Worsening rosacea and eye dryness that may be associated with rosacea. · Healthcare visit (other): Office visit
    MedDRA releases: 2024-11 · check-in free text available
  63. 2022-10-24
    Report sent to call center — day 28, dose 5
    Get care from a doctor or other healthcare professional
    1 call case(s)
  64. 2022-10-26
  65. 2022-11-02
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  66. 2022-11-07
    Survey response — day 42, dose 5
    MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: The worsening of dermatological rosacea and onset of ocular rosacea symptoms persist. I am under treatment. I attribute these to a significant, transient, immune response the morning following vaccination. I will submit an adverse reaction report. · Healthcare visit (other): Office visit.
    MedDRA releases: 2024-11 · check-in free text available
  67. 2022-11-07
    Report sent to call center — day 42, dose 5
    Get care from a doctor or other healthcare professional
    1 call case(s)
  68. 2022-11-08
  69. 2022-11-08
  70. 2022-12-26
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  71. 2023-03-29
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-16Moderna
22021-03-16Moderna
32021-10-26Moderna No
42022-03-30Moderna No
52022-09-26Moderna No

Call center

3 call center cases

1 successful · 2 unsuccessful

See the call center timeline

Free text

Release 4 — day 7, dose 1

2021-02-23

Systemic reaction (other): Runny nose; tender lymph nodes in neck on left side

Release 5 — day 21, dose 1

2021-03-09

Symptoms: Tender neck lymph nodes again (first experienced last Tuesday) and fatigue.

Release 5 — days 1–6 daily, dose 2

2021-03-17

Systemic reaction (other): Briefly light-headed in a.m. so did not drive today

Release 12 — days 1–6 daily, dose 5

2022-09-27

Systemic reaction (other): Sweating and feeling of faintness this morning, and tinnitus

Release 12 — day 14, dose 5

2022-10-10

Symptoms: Worsening of rosacea, for which I am applying my existing prescription for metronidazole cream

Release 12 — day 21, dose 5

2022-10-17

Symptoms: Skin rash and dry eye, which started a few days after vaccination, has not significantly improved. I am following ophthalmologist advice for home care and have a follow up appointment on Friday. I have been unable to wear contact lenses.
Healthcare visit (other): Visit to doctor office

Release 12 — day 28, dose 5

2022-10-24

Symptoms: Worsening rosacea and eye dryness that may be associated with rosacea.
Healthcare visit (other): Office visit

Release 12 — day 42, dose 5

2022-11-07

Symptoms: The worsening of dermatological rosacea and onset of ocular rosacea symptoms persist. I am under treatment. I attribute these to a significant, transient, immune response the morning following vaccination. I will submit an adverse reaction report.
Healthcare visit (other): Office visit.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDCondition aggravated · · ✓
SDContact lens intolerance · · ✓
SDCorrective lens user · · ✓
SDDry eye · · ✓
SDFatigue ✓ ✓ ✓
SDLymph node pain ✓ ✓ ✓
SDPre-existing disease · · ✓
SDRash · · ✓
SDRosacea · · ✓
SRODizziness ✓ ✓ ✓
SROHyperhidrosis · · ✓
SROImpaired driving ability ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROTinnitus · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release